Factor Xa inhibitors (Berlex/Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFactor Xa inhibitors (Berlex/Pfizer)
Drug Alias NameFactor Xa antagonists (Schering AG/Pfizer)ZK-805412 analogsFactor Xa inhibitors (Berlex/Warner-Lambert)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBerlex Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWarner LambertPfizer IncBerlex Biosciences Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A